c-MYC expression in T (III/IV) stage oral squamous cell carcinoma (OSCC) patients [Corrigendum]

Lin SH, Wang HK, Yeh KT, et al. Cancer Manag Res. 2019;11:5163–5169.Following a review of the paper post-publication, the authors found two errors.The authors advised that firstly, they incorrectly listed the CCH IRB number on page 5164. Therefore, the sentence &ldquo...

Full description

Bibliographic Details
Main Authors: Lin SH, Wang HK, Yeh KT, Tai HC, Wang HY, Huang LR, Chiu CW, Chung CM, Velmurugan BK
Format: Article
Language:English
Published: Dove Medical Press 2019-08-01
Series:Cancer Management and Research
Online Access:https://www.dovepress.com/httpssitesgooglecomsitecorrigendum-dmpiheguiderevisedaugus-peer-reviewed-article-CMAR
_version_ 1818926406871023616
author Lin SH
Wang HK
Yeh KT
Tai HC
Wang HY
Huang LR
Chiu CW
Chung CM
Velmurugan BK
author_facet Lin SH
Wang HK
Yeh KT
Tai HC
Wang HY
Huang LR
Chiu CW
Chung CM
Velmurugan BK
author_sort Lin SH
collection DOAJ
description Lin SH, Wang HK, Yeh KT, et al. Cancer Manag Res. 2019;11:5163–5169.Following a review of the paper post-publication, the authors found two errors.The authors advised that firstly, they incorrectly listed the CCH IRB number on page 5164. Therefore, the sentence “This study was approved by the Ethics Committees of Changhua Christian Hospital (Changhua, Taiwan), and we adhered to the guidelines approved by CCH IRB (no. 170143).” should instead read “This study was approved by the Ethics Committees of Changhua Christian Hospital (Changhua, Taiwan), and we adhered to the guidelines approved by CCH IRB (no. 170413).”The authors advised that secondly, they incorrectly listed the wrong protein name in Table 3 on page 5167. This was the result of a typing error when they reviewed the manuscript. The title “The effect of clinicopathologic factor and UNC13C expression on mortality density and adjusted hazard ratio (aHR) among OSCC patients” should instead read “The effect of clinicopathologic factor and c-MYC expression on mortality density and adjusted hazard ratio (aHR) among OSCC patients.”Read the original article
first_indexed 2024-12-20T02:56:37Z
format Article
id doaj.art-c98d89bb67364a7a9678cb45b740d94d
institution Directory Open Access Journal
issn 1179-1322
language English
last_indexed 2024-12-20T02:56:37Z
publishDate 2019-08-01
publisher Dove Medical Press
record_format Article
series Cancer Management and Research
spelling doaj.art-c98d89bb67364a7a9678cb45b740d94d2022-12-21T19:55:54ZengDove Medical PressCancer Management and Research1179-13222019-08-01Volume 117513751447723c-MYC expression in T (III/IV) stage oral squamous cell carcinoma (OSCC) patients [Corrigendum]Lin SHWang HKYeh KTTai HCWang HYHuang LRChiu CWChung CMVelmurugan BKLin SH, Wang HK, Yeh KT, et al. Cancer Manag Res. 2019;11:5163–5169.Following a review of the paper post-publication, the authors found two errors.The authors advised that firstly, they incorrectly listed the CCH IRB number on page 5164. Therefore, the sentence “This study was approved by the Ethics Committees of Changhua Christian Hospital (Changhua, Taiwan), and we adhered to the guidelines approved by CCH IRB (no. 170143).” should instead read “This study was approved by the Ethics Committees of Changhua Christian Hospital (Changhua, Taiwan), and we adhered to the guidelines approved by CCH IRB (no. 170413).”The authors advised that secondly, they incorrectly listed the wrong protein name in Table 3 on page 5167. This was the result of a typing error when they reviewed the manuscript. The title “The effect of clinicopathologic factor and UNC13C expression on mortality density and adjusted hazard ratio (aHR) among OSCC patients” should instead read “The effect of clinicopathologic factor and c-MYC expression on mortality density and adjusted hazard ratio (aHR) among OSCC patients.”Read the original articlehttps://www.dovepress.com/httpssitesgooglecomsitecorrigendum-dmpiheguiderevisedaugus-peer-reviewed-article-CMAR
spellingShingle Lin SH
Wang HK
Yeh KT
Tai HC
Wang HY
Huang LR
Chiu CW
Chung CM
Velmurugan BK
c-MYC expression in T (III/IV) stage oral squamous cell carcinoma (OSCC) patients [Corrigendum]
Cancer Management and Research
title c-MYC expression in T (III/IV) stage oral squamous cell carcinoma (OSCC) patients [Corrigendum]
title_full c-MYC expression in T (III/IV) stage oral squamous cell carcinoma (OSCC) patients [Corrigendum]
title_fullStr c-MYC expression in T (III/IV) stage oral squamous cell carcinoma (OSCC) patients [Corrigendum]
title_full_unstemmed c-MYC expression in T (III/IV) stage oral squamous cell carcinoma (OSCC) patients [Corrigendum]
title_short c-MYC expression in T (III/IV) stage oral squamous cell carcinoma (OSCC) patients [Corrigendum]
title_sort c myc expression in t iii iv stage oral squamous cell carcinoma oscc patients corrigendum
url https://www.dovepress.com/httpssitesgooglecomsitecorrigendum-dmpiheguiderevisedaugus-peer-reviewed-article-CMAR
work_keys_str_mv AT linsh cmycexpressionintiiiivstageoralsquamouscellcarcinomaosccpatientscorrigendum
AT wanghk cmycexpressionintiiiivstageoralsquamouscellcarcinomaosccpatientscorrigendum
AT yehkt cmycexpressionintiiiivstageoralsquamouscellcarcinomaosccpatientscorrigendum
AT taihc cmycexpressionintiiiivstageoralsquamouscellcarcinomaosccpatientscorrigendum
AT wanghy cmycexpressionintiiiivstageoralsquamouscellcarcinomaosccpatientscorrigendum
AT huanglr cmycexpressionintiiiivstageoralsquamouscellcarcinomaosccpatientscorrigendum
AT chiucw cmycexpressionintiiiivstageoralsquamouscellcarcinomaosccpatientscorrigendum
AT chungcm cmycexpressionintiiiivstageoralsquamouscellcarcinomaosccpatientscorrigendum
AT velmuruganbk cmycexpressionintiiiivstageoralsquamouscellcarcinomaosccpatientscorrigendum